DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Reset all filters
01 3Dr. Reddy's Laboratories
02 1Polfa Tarchomin
03 1NanoAlvand
04 1Supriya Lifescience
05 17Accord healthcare
06 1Actavis Inc
07 1Amneal Pharmaceuticals
08 1Aurobindo Pharma Limited
09 2Bristol Laboratories Ltd
10 8Bristol Myers Squibb
11 3Celgene Corporation
12 1CinnaGen Co
13 1Cipla
14 1DR REDDY'S LABORATORIES LTD
15 14Dr Reddy's Laboratories (Australia) Pty Ltd
16 1Dr Reddy's Laboratories (Pty) Ltd
17 14Eugia Pharma
18 1Fresenius Kabi Austria
19 1GetWell Pharmaceutical
20 1Hainan Poly Pharm
21 1Hansoh Pharma
22 1Hetero Drugs
23 2Hikma Pharmaceuticals
24 1Ideogen AG
25 1JAMP PHARMA
26 1Jodas Expoim Pvt. Ltd
27 28Juno Pharmaceuticals Pty Ltd
28 1Key Oncologics
29 1Lupin Ltd
30 1MSN Laboratories
31 1Meitheal Pharmaceuticals
32 1Natco Pharma
33 1Norvium
34 1ORIFARM GROUP AS
35 1Panacea Biotec Limited
36 1SEACROSS PHARMACEUTICALS
37 1Sakar Healthcare
38 2Samyang Biopharmaceuticals
39 16Sandoz B2B
40 1Shilpa Medicare
41 3Spirig Healthcare
42 1Sun Pharmaceutical Industries Limited
43 14Teva Pharma Australia
44 2TherDose Pharma
45 1Vama Lifecare
46 2Viatris
Reset all filters
01 1Azacitidina 25Mg/Ml 100Mg 1 Unit Parenteral Use
02 9Dry Sub
03 1FREEZE-DRIED POWDER
04 2INJ
05 1IV
06 1Injectable
07 10Injection
08 1Lyo.Inj
09 2Lyophilized Injection
10 6POWDER FOR SUSPENSION
11 16POWDER;INTRAVENOUS, SUBCUTANEOUS
12 1PULVER TILL INJEKTIONSVÄTSKA, SUSPENSION
13 1Powder for Solution for Injection
14 1Powder for infusion, solution
15 2Powder for injection fluid, suspension
16 2TABLET
17 2TABLET;ORAL
18 1Vial
19 98injection
20 3Blank
Reset all filters
01 2DISCN
02 1Dossier Available
03 4Generic
04 1Lead Market Dossiers- Approved in both US & EU
05 1Lead Market Dossiers- Filed
06 1Originator
07 8Prescription
08 16RX
09 127Blank
Reset all filters
01 1AZACITE
02 15AZACITIDINE
03 14AZACITIDINE EUGIA
04 5AZACITIDINE FOR INJECTION
05 2AZALID
06 15Azacitidine Accord
07 1Azacitidine DRL
08 14Azacitidine Dr.Reddy's
09 1Azacitidine Ideogen
10 14Azacitidine Juno
11 14Azacitidine MSN
12 1Azacitidine Mylan
13 1Azacitidine SUN
14 15Azacitidine Sandoz
15 1Azacitidine Spirig HC
16 2Azacitidine Stada
17 1Azacitidine Viatris
18 14Azacitidine-Teva
19 1CAPETED
20 1Intaza
21 2Leukaza
22 4ONUREG
23 3Onureg
24 2VIDAZA
25 6Vidaza
26 11Blank
Reset all filters
01 101Australia
02 8Canada
03 1China
04 10India
05 2Iran
06 1Italy
07 3Norway
08 1Poland
09 3South Africa
10 2South Korea
11 1Sweden
12 9Switzerland
13 18USA
14 1United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2013-09-16
Application Number : 201537
Regulatory Info : RX
Registration Country : USA
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Available
Registration Country : Poland
Brand Name :
Dosage Form : Powder for Solution for Injection
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Available
Registration Country : Poland
Regulatory Info :
Registration Country : Iran
Brand Name : Leukaza
Dosage Form : Vial
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Supriya Lifesciences is a cGMP-compliant API manufacturing organization with a leadership position across key & niche products.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in both US & EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in both US & EU
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2018-07-02
Application Number : 207475
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2016-04-29
Application Number : 208216
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2022-02-03
Application Number : 211549
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ONUREG
Dosage Form : TABLET;ORAL
Dosage Strength : 200MG
Packaging :
Approval Date : 2020-09-01
Application Number : 214120
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : ONUREG
Dosage Form : TABLET;ORAL
Dosage Strength : 300MG
Packaging :
Approval Date : 2020-09-01
Application Number : 214120
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : VIDAZA
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2004-05-19
Application Number : 50794
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2018-05-04
Application Number : 209540
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2020-06-08
Application Number : 209337
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2019-02-27
Application Number : 210748
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2020-11-02
Application Number : 212128
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2024-05-16
Application Number : 212580
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2017-06-23
Application Number : 207234
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2016-04-28
Application Number : 204949
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AZACITIDINE
Dosage Form : POWDER;INTRAVENOUS, SUBCUTANEOUS
Dosage Strength : 100MG/VIAL
Packaging :
Approval Date : 2016-09-29
Application Number : 207518
Regulatory Info : RX
Registration Country : USA